الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 85 |  |  |
| | | from | 85 | | |
Abstract
The brachial AAPL can offer a simple, safe, and efficient alternative as a permanent HD access in a selected subset of ESRD patients, with acceptable durability and rate of complications. Because of its unique specifications, cooperation between vascular surgeons and dialysis staff is mandatory.
On reviewing the scientific literature; the rate of complications is slightly higher than that with usual synthetic AVF, although it is still acceptable in this population of no option for access. Number of complications can be reduced by adhering to instructions such as proper compression and periodic follow-up. Complications are expected to occur less often as this type of access becomes more familiar to patients and dialysis staff.
Further work is needed to evaluate long-term results of PTFE AAG and to introduce the use of other new graft materials (eg; flexine) as well. Lack of enough scientific evidence on the use of arterio-arterial access clearly shows the need for a multi-center study including a large number of patients to reach consensus on the ideal site, technique, configuration, and postoperative antithrombotic agents (antiplatelets vs anticoagulants) concerning this unique access.